Probiotec Limited

ASX:PBP.AX

2.98 (AUD) • At close June 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q42008 Q22007 Q42007 Q22006 Q42006 Q2
Revenue 113.962107.258106.7797.16785.16177.92442.58363.11144.10942.0533.03338.9527.48731.27327.71732.80329.93232.8429.29734.10732.20833.67134.05933.02333.02335.88535.88537.5241.5843.57343.57333.06916.53526.99613.49800
Cost of Revenue 84.84876.377.467.64959.87357.59127.82445.02931.27628.38122.15825.74417.84419.49517.30620.81519.08821.17118.63121.70619.83619.08418.3218.39618.39618.9218.9218.03318.03321.42821.42818.8669.43316.9078.45400
Gross Profit 29.11330.95929.3729.51825.28720.33214.75918.08312.83313.66910.87413.2069.64411.77910.41111.98810.84411.66810.66612.40112.37214.58815.73914.62714.62716.96516.96519.48723.54722.14522.14514.2047.10210.0895.04400
Gross Profit Ratio 0.2550.2890.2750.3040.2970.2610.3470.2870.2910.3250.3290.3390.3510.3770.3760.3650.3620.3550.3640.3640.3840.4330.4620.4430.4430.4730.4730.5190.5440.5080.5080.430.430.3740.37400
Reseach & Development Expenses 00.51300.3180000.30300.31200.721000000.79701.59301.06401.0921.0921.7471.7472.0822.0821.8151.8151.6190.8091.1210.56100
General & Administrative Expenses 18.05914.99814.84912.86413.37508.7756.8516.144.6315.2327.3055.040.2444.2720.2234.2040.2235.4450.2435.8260.3035.9670.460.460.4660.4660.3260.3260.3220.3220.2670.1333.0151.50800
Selling & Marketing Expenses 7.6026.5867.1716.5624.88903.5274.3843.5793.363.4272.5533.9955.5124.9725.676.0246.0765.8146.6286.5238.3478.6989.4589.45810.35710.35710.48910.48910.79310.7935.652.8253.171.58500
SG&A 20.98620.07619.52118.32616.84812.71311.52610.7779.0979.1658.669.8589.0355.7569.2445.89410.2276.29911.2596.87112.3498.65114.6649.9199.91910.82310.82310.81510.81511.11511.1155.9172.9586.1863.09300
Other Expenses 00000.0520000-0.043-0.04300.512-1.649-0.825-1.590-1.9620-3.0210-4.8980-6.57510.161-7.9548.447-7.3998.831-8.9188.948-4.554-2.277-5.541-2.77100
Operating Expenses 20.98620.07619.52118.32616.79612.71311.52610.7779.0979.1658.5219.1549.0234.1079.2444.30410.1855.13411.1145.44310.694.81614.5434.43628.0974.61630.1535.49730.1524.01229.0832.9821.4911.7660.88300
Operating Income 8.12710.8829.84911.1928.4927.6193.2337.3063.7364.5042.2153.3480.6091.9161.1671.7910.6170.236-0.593-0.2890.0231.1211.0870.273-3.5511.525-2.3653.1750.097.0184.1775.3062.6533.9031.95200
Operating Income Ratio 0.0710.1010.0920.1150.10.0980.0760.1160.0850.1070.0670.0860.0220.0610.0420.0550.0210.007-0.02-0.0080.0010.0330.0320.008-0.050.043-0.0120.0850.0410.1610.1280.160.160.1450.14500
Total Other Income Expenses Net -3.171-2.849-2.3080.565-2.213-2.051-1.081-0.907-1.238-0.856-0.6480.261-0.217-0.143-0.183-0.247-0.355-2.925-0.4990.6641.017-0.349-0.7160.8464.67-2.3941.4971.8864.971-0.9931.848-1.055-0.528-0.872-0.43600
Income Before Tax 4.9568.0337.54111.7576.2795.5672.1526.3992.4993.6481.5673.6090.3911.7730.9841.5440.262-2.689-1.0930.3751.0410.7720.3711.1191.119-0.869-0.8695.0615.0616.0256.0254.252.1253.0311.51500
Income Before Tax Ratio 0.0430.0750.0710.1210.0740.0710.0510.1010.0570.0870.0470.0930.0140.0570.0360.0470.009-0.082-0.0370.0110.0320.0230.0110.0340.034-0.024-0.0240.1350.1280.1380.1380.1290.1290.1120.11200
Income Tax Expense 1.8282.4762.082.4931.8361.7360.9141.7620.6930.7250.470.8740.0710.5180.1550.3740.039-0.3040.133-0.0990.0420.0360.0650.0040.0040.1730.1730.320.321.5751.5751.0960.5480.5420.27100
Net Income 3.1285.5575.4619.2644.4433.6081.2382.8150.691-1.5891.0972.7350.3211.1320.8292.0070.301-12.371-0.9590.4520.9980.2980.3050.6250.625-5.169-5.1694.744.744.454.453.1551.5772.4891.24400
Net Income Ratio 0.0270.0520.0510.0950.0520.0460.0290.0450.016-0.0380.0330.070.0120.0360.030.0610.01-0.377-0.0330.0130.0310.0090.0090.0190.019-0.144-0.1440.1260.120.1020.1020.0950.0950.0920.09200
EPS 0.0390.0680.0670.110.0560.0450.0170.0380.01-0.0270.0170.0420.0050.0210.0160.0380.006-0.24-0.0180.0090.0190.0060.0060.0120.012-0.098-0.1020.0910.0890.0880.1020.0650.0330.0540.02700
EPS Diluted 0.0370.0670.0660.110.0560.0450.0170.0380.01-0.0270.0170.0420.0050.0210.0160.0380.006-0.24-0.0180.0090.0190.0060.0060.0120.012-0.098-0.1020.0910.0890.0880.0920.0650.0330.0540.02700
EBITDA 12.80221.80312.9714.2019.82613.1835.84210.1866.0176.3212.395.5480.6963.2652.2974.1492.402-9.8941.3023.2761.5032.9142.6523.5474.528-1.9129.4597.4647.4648.4848.4846.3953.1984.8842.44200
EBITDA Ratio 0.1120.2030.1160.1360.1150.1690.1370.1610.1360.150.0720.1420.0250.1040.0830.1260.08-0.3010.0440.0960.0470.0870.0780.1070.122-0.0530.1050.1990.1890.1950.1950.1930.1930.1810.18100